Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Rothman

Showing results (931-940 of 952) with videos related to

Pageof 96
Sort By:
American Heart Journal|December 28, 2025
Dual versus monotherapy with SGLT2 inhibitor and GLP-1 receptor agonist:PRECIDENTD pragmatic randomized trialDeborah J Wexler, Lindsay S Mayberry, Lyndsay A Nelson, et al.
Contemporary Clinical Trials|July 27, 2025
Association of study visit interval length with follow-up completeness and adherence to assigned study drug dose: A randomized comparison of participants in the ADAPTABLE trialDennis I Narcisse, Jeff Whittle, Grace M Rhodes, et al.
Plos One|February 2, 2023
Quantifying heterogeneities in arbovirus transmission: Description of the rationale and methodology for a prospective longitudinal study of dengue and Zika virus transmission in Iquitos, Peru (2014-2019)Amy C Morrison, Valerie A Paz-Soldan, Gonzalo M Vazquez-Prokopec, et al.
Medrxiv : the Preprint Server for Health Sciences|August 20, 2025
Metformin on the Presence of COVID-19 Symptoms Over 6 Months: The ACTIV-6 Randomized Clinical TrialCarolyn T Bramante, Thomas G Stewart, David R Boulware, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2022
Effect of Ivermectin 600 μg/kg for 6 days vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical TrialSusanna Naggie, David R Boulware, Christopher J Lindsell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2026
Metformin on the Presence of COVID-19 Symptoms 6 Months after Infection: The ACTIV-6 Randomized Clinical TrialCarolyn T Bramante, Thomas G Stewart, David R Boulware, et al.
Journal of the American Heart Association|February 13, 2024
Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular DiseaseGuillaume Marquis-Gravel, Amanda Stebbins, Lisa M Wruck, et al.
Journal of Neurochemistry|January 6, 2024
Brain energy metabolism: A roadmap for future researchCaroline D Rae, Joseph A Baur, Karin Borges, et al.
Contemporary Clinical Trials|August 9, 2021
Design of the Healthcare Worker Exposure Response and Outcomes (HERO) research platformAnne Friedland, Adrian F Hernandez, Kevin J Anstrom, et al.
JAMA Internal Medicine|July 14, 2025
Metformin and Time to Sustained Recovery in Adults With COVID-19: The ACTIV-6 Randomized Clinical TrialCarolyn T Bramante, Thomas G Stewart, David R Boulware, et al.
Pageof 96

Showing results (931-940 of 952) with videos related to

Sort By:
Pageof 96
American Heart Journal|December 28, 2025
Dual versus monotherapy with SGLT2 inhibitor and GLP-1 receptor agonist:PRECIDENTD pragmatic randomized trialDeborah J Wexler, Lindsay S Mayberry, Lyndsay A Nelson, et al.
Contemporary Clinical Trials|July 27, 2025
Association of study visit interval length with follow-up completeness and adherence to assigned study drug dose: A randomized comparison of participants in the ADAPTABLE trialDennis I Narcisse, Jeff Whittle, Grace M Rhodes, et al.
Plos One|February 2, 2023
Quantifying heterogeneities in arbovirus transmission: Description of the rationale and methodology for a prospective longitudinal study of dengue and Zika virus transmission in Iquitos, Peru (2014-2019)Amy C Morrison, Valerie A Paz-Soldan, Gonzalo M Vazquez-Prokopec, et al.
Medrxiv : the Preprint Server for Health Sciences|August 20, 2025
Metformin on the Presence of COVID-19 Symptoms Over 6 Months: The ACTIV-6 Randomized Clinical TrialCarolyn T Bramante, Thomas G Stewart, David R Boulware, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2022
Effect of Ivermectin 600 μg/kg for 6 days vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical TrialSusanna Naggie, David R Boulware, Christopher J Lindsell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2026
Metformin on the Presence of COVID-19 Symptoms 6 Months after Infection: The ACTIV-6 Randomized Clinical TrialCarolyn T Bramante, Thomas G Stewart, David R Boulware, et al.
Journal of the American Heart Association|February 13, 2024
Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular DiseaseGuillaume Marquis-Gravel, Amanda Stebbins, Lisa M Wruck, et al.
Journal of Neurochemistry|January 6, 2024
Brain energy metabolism: A roadmap for future researchCaroline D Rae, Joseph A Baur, Karin Borges, et al.
Contemporary Clinical Trials|August 9, 2021
Design of the Healthcare Worker Exposure Response and Outcomes (HERO) research platformAnne Friedland, Adrian F Hernandez, Kevin J Anstrom, et al.
JAMA Internal Medicine|July 14, 2025
Metformin and Time to Sustained Recovery in Adults With COVID-19: The ACTIV-6 Randomized Clinical TrialCarolyn T Bramante, Thomas G Stewart, David R Boulware, et al.
Pageof 96